Jw Life Science Corp (234080) — Free Cash Flow Generation Index
Jw Life Science Corp (234080) has a Free Cash Flow Generation Index of 0.16x as of December 2025. Free cash flow of ₩809.90 Million represents 0% of operating cash flow (₩5.08 Billion). See how liquid is Jw Life Science Corp's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jw Life Science Corp Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Jw Life Science Corp across 11 annual periods. Explore 234080 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Jw Life Science Corp (2015–2025)
Year-by-year Free Cash Flow Generation Index for Jw Life Science Corp. For the full company profile including market capitalisation, see Jw Life Science Corp (234080) total market value.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | ₩27.10 Billion | ₩40.54 Billion | ₩13.43 Billion | ▼ -16.1% |
| 2024 | 0.80x | ₩40.38 Billion | ₩50.69 Billion | ₩10.31 Billion | ▲ +2.1% |
| 2023 | 0.78x | ₩29.31 Billion | ₩37.57 Billion | ₩8.27 Billion | ▲ +88.9% |
| 2022 | 0.41x | ₩5.84 Billion | ₩14.13 Billion | ₩8.29 Billion | ▲ +15.7% |
| 2021 | 0.36x | ₩10.77 Billion | ₩30.17 Billion | ₩18.98 Billion | ▼ -45.3% |
| 2020 | 0.65x | ₩30.52 Billion | ₩46.75 Billion | ₩15.93 Billion | ▼ -0.5% |
| 2019 | 0.66x | ₩15.92 Billion | ₩24.28 Billion | ₩8.09 Billion | ▼ -7.3% |
| 2018 | 0.71x | ₩25.57 Billion | ₩36.13 Billion | ₩10.04 Billion | ▲ +18.2% |
| 2017 | 0.60x | ₩13.20 Billion | ₩22.05 Billion | ₩8.77 Billion | ▼ -67.3% |
| 2016 | 1.83x | ₩29.45 Billion | ₩16.08 Billion | ₩13.37 Billion | ▼ -3.3% |
| 2015 | 1.89x | ₩49.03 Billion | ₩25.90 Billion | ₩23.14 Billion | — |